\u201cConcerns have been raised\u201d relating to respect for \u201cpublication ethics\u201d of the journal\u2019s publisher, and \u201cthe appropriate conduct of research involving human participants, as well as concerns raised by three of the authors themselves regarding the article\u2019s methodology and conclusions,\u201d stated Elsevier, the publisher of the scientific journal International Journal of Antimicrobial Agents<\/i>, in a lengthy note justifying this rare retraction. <\/p>\n
The article, signed by 18 authors, notably Philippe Gautret, then a professor at the Marseille IHU, and Didier Raoult, who directed this institute, intended to demonstrate the efficacy of hydroxychloroquine, combined with an antibiotic \u2013 azithromycin \u2013 against COVID-19.<\/p>\n","protected":false},"excerpt":{"rendered":"
\u201cConcerns have been raised\u201d relating to respect for \u201cpublication ethics\u201d of the journal\u2019s publisher, and \u201cthe appropriate conduct of research involving human participants, as well as concerns raised by three of the authors themselves regarding the article\u2019s methodology and conclusions,\u201d stated Elsevier, the publisher of the scientific journal International Journal of Antimicrobial Agents<\/i>, in a lengthy note justifying this rare retraction. <\/p>\n
The article, signed by 18 authors, notably Philippe Gautret, then a professor at the Marseille IHU, and Didier Raoult, who directed this institute, intended to demonstrate the efficacy of hydroxychloroquine, combined with an antibiotic \u2013 azithromycin \u2013 against COVID-19.<\/p>\n